Kennedy plans to deliver a report on environmental causes of autism this month and his vaccine advisory committee will meet Sept. 18 to discuss COVID booster availability. Simplified dietary guidelines and a presidential report on reducing chronic disease in children are also expected. New members of senior leadership will be installed in coming weeks, according to CDC acting director Jim O'Neill. President Trump questioned the safety and effectiveness of COVID shots after Kennedy limited access and urged pharmaceutical companies to substantiate their success. Critics say Kennedy has legally manipulated bureaucracy to restrict vaccine access without banning shots, and medical associations and former CDC directors are mobilizing opposition. Some blue states may issue separate public health guidance, and Senate oversight has been proposed.
President Trump on Monday questioned whether the COVID shots developed during his first term are safe and effective after Kennedy limited who can get them, and said that pharmaceutical companies need to publicly substantiate their success. Zoom in: Kennedy has been legally adept at "manipulating the bureaucracy" around COVID vaccines, said Angela Rasmussen, a virologist at the University of Saskatchewan and a vocal Kennedy critic. The result is effectively limiting access to the shots without technically banning them.
Friction points: Kennedy said last week that he expects to deliver a report on the environmental causes of autism this month. His handpicked vaccine advisory committee is set to meet on the availability of COVID boosters on Sept. 18. Also expected are simplified dietary guidelines and a presidentially commissioned report on ways to reduce chronic disease in children. New members of senior leadership will be installed in the coming weeks, CDC acting director Jim O'Neill, a top adviser to Kennedy, wrote on X.
Collection
[
|
...
]